Immuron
IMRN
4 hedge funds and large institutions have $13.3K invested in Immuron in 2023 Q4 according to their latest regulatory filings, with funds opening new positions, increasing their positions, 1 reducing their positions, and closing their positions.
0% more funds holding
Funds holding: 4 → 4 (0)
0.01% less ownership
Funds ownership: 0.14% → 0.12% (-0.01%)
15% less capital invested
Capital invested by funds: $15.6K → $13.3K (-$2.33K)
100% less repeat investments, than reductions
Existing positions increased: 0 | Existing positions reduced: 1
Top Buyers
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Morgan Stanley
New York
|
-$1.48K |
IMRN Hedge Fund Activity: Q4 2023 in Review
4 of the 6,871 institutional investors tracked by Wall St. Rank reported a position in Immuron (IMRN) for Q4 2023, worth a combined $13.3K — down 15% from $15.6K a quarter earlier.
Fund positioning in IMRN was balanced in Q4 2023: 0 funds opened new positions, 0 closed out, 0 added to existing stakes and 1 trimmed.
The largest seller was Morgan Stanley, cutting an estimated $1.48K.
- 4 institutional investors held Immuron (IMRN) as of Q4 2023, unchanged from Q3 2023.
- Funds reported $13.3K of Immuron stock for Q4 2023, down 15% quarter-over-quarter.
- 0 funds opened new Immuron positions in Q4 2023 and 0 closed out.
- The largest Immuron seller in Q4 2023 was Morgan Stanley, an estimated $1.48K sold.
Based on aggregated 13F filings for Q4 2023.